Alphatec Holdings (ATEC) Asset Writedowns and Impairment (2010 - 2026)
Alphatec Holdings' (ATEC) quarterly Asset Writedowns and Impairment came in at $4.5 million in Q2 2026, up 2.42% year-over-year from $4.4 million in Q2 2025, and up 23.87% quarter-over-quarter from $3.6 million in Q1 2026.
Analysis
Alphatec Holdings (ATEC) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
Alphatec Holdings has disclosed Asset Writedowns and Impairment across 17 years of filings, most recently posting $4.5 million for Q2 2026.
- In Q2 2026, Asset Writedowns and Impairment rose 2.42% year-over-year to $4.5 million; the TTM figure through Jun 2026 stood at $13.7 million (down 17.09% YoY), while the FY2025 annual figure was $13.5 million, down 12.23% from the prior year.
- Asset Writedowns and Impairment came in at $4.5 million for Q2 2026 at Alphatec Holdings, up from $3.6 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $4.6 million in Q2 2023 to a low of $1.7 million in Q1 2022.
- Average Asset Writedowns and Impairment over 5 years is $3.4 million, with a median of $3.5 million recorded in 2025.
- Year-over-year, Asset Writedowns and Impairment jumped 93.65% in 2023 and slumped 50.3% in 2025.
- Over 5 years, Asset Writedowns and Impairment stood at $2.8 million in 2022, then surged by 59.16% to $4.4 million in 2023, then grew by 0.7% to $4.5 million in 2024, then tumbled by 50.3% to $2.2 million in 2025, then jumped by 102.49% to $4.5 million in 2026.
- Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $4.5 million in Q2 2026, $3.6 million in Q1 2026, and $2.2 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Alphatec Holdings | 1.38 Bn | 1.26 Bn | 154.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.48 Mn |
| Mar 31, 2026 | 3.62 Mn |
| Dec 31, 2025 | 2.21 Mn |
| Sep 30, 2025 | 3.38 Mn |
| Jun 30, 2025 | 4.37 Mn |
| Mar 31, 2025 | 3.57 Mn |
| Dec 31, 2024 | 4.45 Mn |
| Sep 30, 2024 | 4.11 Mn |
| Jun 30, 2024 | 3.88 Mn |
| Mar 31, 2024 | 2.98 Mn |
| Dec 31, 2023 | 4.42 Mn |
| Sep 30, 2023 | 2.45 Mn |
| Jun 30, 2023 | 4.64 Mn |
| Mar 31, 2023 | 2.10 Mn |
| Dec 31, 2022 | 2.78 Mn |
| Sep 30, 2022 | 2.92 Mn |
| Jun 30, 2022 | 2.39 Mn |
| Mar 31, 2022 | 1.71 Mn |
| Dec 31, 2021 | 4.31 Mn |
| Sep 30, 2021 | 2.53 Mn |